Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 1990. Start Trial.
Date Value
September 30, 2026 74.70%
August 31, 2026 74.70%
July 31, 2026 74.70%
June 30, 2026 74.70%
May 31, 2026 74.70%
April 30, 2026 74.70%
March 31, 2026 74.70%
February 28, 2026 73.71%
January 31, 2026 68.48%
December 31, 2025 68.48%
November 30, 2025 68.48%
October 31, 2025 68.48%
September 30, 2025 68.48%
August 31, 2025 68.48%
July 31, 2025 67.31%
June 30, 2025 59.66%
May 31, 2025 59.66%
April 30, 2025 59.66%
March 31, 2025 52.65%
February 28, 2025 46.79%
January 31, 2025 46.23%
December 31, 2024 41.92%
November 30, 2024 31.80%
October 31, 2024 23.65%
September 30, 2024 23.65%
Date Value
August 31, 2024 23.65%
July 31, 2024 23.65%
June 30, 2024 23.65%
May 31, 2024 23.65%
April 30, 2024 23.65%
March 31, 2024 23.65%
February 29, 2024 23.65%
January 31, 2024 23.65%
December 31, 2023 23.65%
November 30, 2023 23.65%
October 31, 2023 23.81%
September 30, 2023 26.66%
August 31, 2023 26.66%
July 31, 2023 26.66%
June 30, 2023 26.66%
May 31, 2023 26.66%
April 30, 2023 26.66%
March 31, 2023 26.66%
February 28, 2023 26.66%
January 31, 2023 26.66%
December 31, 2022 26.66%
November 30, 2022 26.66%
October 31, 2022 26.66%
September 30, 2022 26.66%
August 31, 2022 26.66%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
AstraZeneca PLC 27.87%
GSK Plc 39.39%
Johnson & Johnson 18.44%
Eli Lilly & Co. 34.47%
Merck & Co., Inc. 43.45%